These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19877202)

  • 1. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
    Rascol O; Schelosky L
    Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
    Taki J; Yoshita M; Yamada M; Tonami N
    Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
    King AE; Mintz J; Royall DR
    Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical significance of MIBG myocardial scintigraphy in Parkinson disease].
    Orimo S
    Brain Nerve; 2012 Apr; 64(4):403-12. PubMed ID: 22481513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
    Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E
    PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
    Kashihara K; Ohno M; Kawada S; Okumura Y
    J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.
    Nakajima K; Yoshita M; Matsuo S; Taki J; Kinuya S
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):378-87. PubMed ID: 19088692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.
    Orimo S; Yogo M; Nakamura T; Suzuki M; Watanabe H
    Ageing Res Rev; 2016 Sep; 30():122-33. PubMed ID: 26835846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac sympathetic innervation imaging with myocardial MIBG scintigraphy].
    Genovese EA; Mallardo V; Cipullo S; Restuccia A; Galea D; D'Agosto G; Di Lanno I; Cappabianca S
    Recenti Prog Med; 2013; 104(7-8):356-60. PubMed ID: 24042407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
    Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
    Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
    Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
    Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
    J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.